ENCODE cell lines, expression (Ernst 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MYB | hg19_v2_chr6_+_135502501_135502652 | 0.95 | 2.4e-08 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_85155939 | 3.50 |
ENST00000603677.1 |
SSX2IP |
synovial sarcoma, X breakpoint 2 interacting protein |
chr11_-_67888671 | 3.36 |
ENST00000265689.4 |
CHKA |
choline kinase alpha |
chrX_+_37545012 | 3.25 |
ENST00000378616.3 |
XK |
X-linked Kx blood group (McLeod syndrome) |
chr1_-_85156216 | 2.86 |
ENST00000342203.3 ENST00000370612.4 |
SSX2IP |
synovial sarcoma, X breakpoint 2 interacting protein |
chr14_+_29236269 | 2.77 |
ENST00000313071.4 |
FOXG1 |
forkhead box G1 |
chrX_-_151903101 | 2.69 |
ENST00000393900.3 |
MAGEA12 |
melanoma antigen family A, 12 |
chr1_-_114355083 | 2.63 |
ENST00000261441.5 |
RSBN1 |
round spermatid basic protein 1 |
chr17_+_45286387 | 2.59 |
ENST00000572316.1 ENST00000354968.1 ENST00000576874.1 ENST00000536623.2 |
MYL4 |
myosin, light chain 4, alkali; atrial, embryonic |
chr2_-_111435610 | 2.53 |
ENST00000447014.1 ENST00000420328.1 ENST00000535254.1 ENST00000409311.1 ENST00000302759.6 |
BUB1 |
BUB1 mitotic checkpoint serine/threonine kinase |
chr17_+_45286706 | 2.37 |
ENST00000393450.1 ENST00000572303.1 |
MYL4 |
myosin, light chain 4, alkali; atrial, embryonic |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 4.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 3.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 3.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 2.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.7 | 2.7 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.0 | 2.6 | GO:0031672 | A band(GO:0031672) |
0.0 | 2.6 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 2.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 2.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 6.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 4.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 4.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 4.0 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 3.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 3.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 3.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 3.2 | PID ATM PATHWAY | ATM pathway |
0.1 | 3.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.7 | 2.7 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.7 | 2.6 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.3 | 2.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 2.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 1.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.6 | 1.8 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.2 | 1.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 1.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 1.7 | GO:0031996 | thioesterase binding(GO:0031996) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 2.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 1.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 2.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 2.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 8.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.6 | 5.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 5.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 5.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 5.0 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.2 | 4.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 4.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 4.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 4.0 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.9 | 3.6 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 4.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 2.7 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 2.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 2.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 2.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 1.2 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 1.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.0 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 1.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 10.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 8.2 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 7.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 6.8 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.7 | 6.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 5.4 | GO:0031672 | A band(GO:0031672) |
0.6 | 5.2 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 4.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 3.8 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 2.9 | GO:0005642 | annulate lamellae(GO:0005642) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 3.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 3.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 2.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 3.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 3.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.4 | 3.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 2.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 2.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 2.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 2.1 | GO:0021915 | neural tube development(GO:0021915) |
0.1 | 2.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 1.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 7.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 5.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 4.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 4.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 4.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 3.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 3.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 3.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 3.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 4.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 3.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 2.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 1.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 1.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 1.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 1.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.8 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 2.8 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 2.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.3 | 1.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 1.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 4.5 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.0 | 3.3 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 2.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 2.6 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.0 | 2.4 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.2 | 1.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 1.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 1.2 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 1.2 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.3 | 1.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 19.0 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
1.9 | 5.6 | GO:0004103 | choline kinase activity(GO:0004103) |
1.2 | 5.0 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
1.0 | 3.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 3.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 3.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 3.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 3.4 | GO:0042393 | histone binding(GO:0042393) |
0.7 | 2.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 2.9 | GO:0035064 | methylated histone binding(GO:0035064) |